A Bronx man has sued a Manhattan men’s clinic and its doctor after penile enhancement treatments left him in chronic pain and unable to function sexually, according to a lawsuit filed last week.
The 31-year-old plaintiff, whose name was withheld from the Sept. 17 filing in Manhattan Supreme Court, names Best Man Manhattan and Dr. Amanuel Samad Himmed as responsible for a procedure he says went disastrously wrong. Himmed now practices in Florida, the suit notes.
The clinic markets itself as home to “New York’s leading penis enlargement specialists” and promotes a nonsurgical technique involving microinjections of phallic fillers. Its website claims the method stimulates collagen production for “permanent, lifetime enlargement.” The procedure carries a price tag of up to $14,950, with Best Man pitching it as a confidence and sexual performance booster.
The man first underwent the filler treatment in May 2024, according to court documents. He returned to the Financial District clinic for a second round in October or November of the same year. Both sessions involved 85 milligrams of Dimethicone Oil, a clear, odorless silicone-based polymer commonly used in cosmetic procedures.
Following the second treatment, the plaintiff developed what the filing describes as “progressive abnormalities and complications, including pain, deformity, skin changes and impairment of sexual and penile function.” The lawsuit seeks unspecified damages for the alleged harm.
“What he has endured has been horrific, and he is doing his best to deal with the ongoing repercussions,” his attorney Ben Bartolotta said in a statement to The Post.
Best Man Manhattan and Himmed did not respond to requests for comment on the allegations.
The case centers on a growing category of cosmetic procedures targeting male genital enhancement, which have drawn increased regulatory scrutiny as complaints about complications have mounted nationally. Dimethicone Oil, the silicone-based substance used in both of the plaintiff’s treatments, is among the fillers employed in such procedures despite documented risks including migration, granuloma formation, and tissue damage.
The lawsuit was filed Sept. 17 in Manhattan Supreme Court.